Annual Short Term Debt
$4.13 M
+$453.00 K+12.33%
December 31, 2023
Summary
- As of February 12, 2025, BBIO annual short term debt is $4.13 million, with the most recent change of +$453.00 thousand (+12.33%) on December 31, 2023.
- During the last 3 years, BBIO annual short term debt has fallen by -$1.13 million (-21.42%).
- BBIO annual short term debt is now -21.42% below its all-time high of $5.25 million, reached on December 31, 2020.
Performance
BBIO Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$4.60 M
-$23.00 K-0.50%
September 30, 2024
Summary
- As of February 12, 2025, BBIO quarterly short term debt is $4.60 million, with the most recent change of -$23.00 thousand (-0.50%) on September 30, 2024.
- Over the past year, BBIO quarterly short term debt has increased by +$472.00 thousand (+11.43%).
- BBIO quarterly short term debt is now -38.28% below its all-time high of $7.45 million, reached on March 31, 2021.
Performance
BBIO Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
BBIO Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.3% | +11.4% |
| 3 y3 years | -21.4% | +11.4% |
| 5 y5 years | - | +11.4% |
BBIO Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.4% | +12.3% | -6.8% | +25.2% |
| 5 y | 5-year | -21.4% | -100.0% | -38.3% | -100.0% |
| alltime | all time | -21.4% | -100.0% | -38.3% | -100.0% |
BridgeBio Pharma Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.60 M(-0.5%) |
| Jun 2024 | - | $4.62 M(+1.7%) |
| Mar 2024 | - | $4.54 M(+10.1%) |
| Dec 2023 | $4.13 M(+12.3%) | $4.13 M(-0.2%) |
| Sep 2023 | - | $4.14 M(+9.6%) |
| Jun 2023 | - | $3.78 M(+2.8%) |
| Mar 2023 | - | $3.67 M(-0.0%) |
| Dec 2022 | $3.67 M | $3.67 M(-9.1%) |
| Sep 2022 | - | $4.04 M(-6.2%) |
| Jun 2022 | - | $4.31 M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $4.36 M(-11.6%) |
| Dec 2021 | $4.94 M(-6.0%) | $4.94 M(-1.2%) |
| Sep 2021 | - | $5.00 M(+10.1%) |
| Jun 2021 | - | $4.54 M(-39.1%) |
| Mar 2021 | - | $7.45 M(+41.9%) |
| Dec 2020 | $5.25 M(>+9900.0%) | $5.25 M(+45.2%) |
| Sep 2020 | - | $3.62 M(-0.3%) |
| Jun 2020 | - | $3.63 M(+44.5%) |
| Mar 2020 | - | $2.51 M(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is BridgeBio Pharma annual short term debt?
- What is the all time high annual short term debt for BridgeBio Pharma?
- What is BridgeBio Pharma annual short term debt year-on-year change?
- What is BridgeBio Pharma quarterly short term debt?
- What is the all time high quarterly short term debt for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly short term debt year-on-year change?
What is BridgeBio Pharma annual short term debt?
The current annual short term debt of BBIO is $4.13 M
What is the all time high annual short term debt for BridgeBio Pharma?
BridgeBio Pharma all-time high annual short term debt is $5.25 M
What is BridgeBio Pharma annual short term debt year-on-year change?
Over the past year, BBIO annual short term debt has changed by +$453.00 K (+12.33%)
What is BridgeBio Pharma quarterly short term debt?
The current quarterly short term debt of BBIO is $4.60 M
What is the all time high quarterly short term debt for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly short term debt is $7.45 M
What is BridgeBio Pharma quarterly short term debt year-on-year change?
Over the past year, BBIO quarterly short term debt has changed by +$472.00 K (+11.43%)